Question

Does sickle cell trait affect my health?

  • Tier B moderate Observed in Black populations
  • Harm signal
  • Last checked 2026-11-12
  • Not yet clinically reviewed

Short answer

A review of 41 observational studies called it largely a benign carrier state that is a risk factor for a few outcomes. It found high-strength evidence for an association with pulmonary embolism, proteinuria and chronic kidney disease, and moderate-strength evidence for exertional rhabdomyolysis. Absolute risks of thromboembolism and rhabdomyolysis were small. See a GP (UK) about persistent protein in the urine or kidney concerns.

What this is based on

  • Largely a benign carrier state, and a risk factor for a few outcomes.Tested Naik 2018
  • Who was tested: 41 observational studies in children and adults. What was found: High-strength evidence for a positive association between trait and pulmonary embolism, proteinuria and chronic kidney disease. Moderate-strength evidence for exertional rhabdomyolysis, and for no association with deep vein thrombosis, heart failure or stroke. Absolute risks of thromboembolism and rhabdomyolysis were small. The authors state that sickle cell trait is largely a benign carrier state that is a risk factor for a few outcomes.Tested Naik 2018 Study page
  • Persistent protein in urine or kidney concerns (doctor).When to see someone

Also asked as

  • does having the sickle cell trait affect you
  • can sickle cell trait cause problems

From the card

Sickle cell trait is one copy of the sickle gene, not sickle cell disease. It raises the risk of serious muscle breakdown in very hard exercise. A soldiers' study found no clear difference in deaths (a wide margin of error); a US college football study found far more exertional deaths. Know your status and train with care.

Where this comes from

Read the full entry: Sickle cell trait and hard exercise

Last checked against its sources: . Next check due: 17 May 2027.

This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence.